The FDA black box for EPO: what should nephrologists do?

Nephrology news & issues

Volumn 21, Issue 6, 2007, Pages

  Singh, Ajay K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; DRUG DERIVATIVE; ERYTHROPOIETIN; HEMOGLOBIN;

ANEMIA; ARTICLE; DRUG TOXICITY; HUMAN; METABOLISM; PRACTICE GUIDELINE; RENAL REPLACEMENT THERAPY; UNITED STATES;

ANEMIA; DRUG TOXICITY; ERYTHROPOIETIN; HEMATINICS; HEMOGLOBINS; HUMANS; PRACTICE GUIDELINES; RENAL DIALYSIS; UNITED STATES;

EID: 34347384042     PISSN: 08961263     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)